
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum Corp is positioned for robust growth due to its strategic focus on market development and penetration, particularly within its core MedSurg segment that addresses critical healing needs. The company's emphasis on accelerating global adoption of antimicrobial solutions and elevating standards of care suggests a commitment to innovation and improved patient outcomes, which could enhance its competitive positioning. Additionally, the anticipated growth in Revenue Cycle Management, driven by expanded capabilities and international expansion, further underlines the company's potential to capitalize on emerging market opportunities.
Bears say
Solventum Corp has faced a persistent decline in volume growth, with the company experiencing seven consecutive quarters of negative volumes prior to its spin-off. Additionally, projections indicate a potential gross margin decline of approximately 40 basis points in 2026, attributed to the anticipated impact of tariffs. These factors contribute to a negative outlook on the company’s financial performance and overall market positioning.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares